Market Place
Sourcing Support
Lisata & Valo Announce Preclinical Research Collaboration
06 Nov 2024 //
GLOBENEWSWIRE
Valo Announces Regulatory Approval to Expand Phase I Immuno-oncology Trial
29 Nov 2023 //
GLOBENEWSWIRE
Valo Announces Acquisition of Bruker`s Latest Mass Spectrometer Platform
10 Oct 2023 //
GLOBENEWSWIRE
ValoTx, Texcell ink collaboration to evaluate immune responses to PeptiCRAd-1
15 Jun 2023 //
PHARMABIZ
Valo Therapeutics and Texcell Announce Research Collaboration
13 Jun 2023 //
GLOBENEWSWIRE
Valo Announces First Patient Dosed with PeptiCRAd-1 - Innovative Immuno-oncology
23 May 2023 //
GLOBENEWSWIRE
Valo Announces European Patents Granted for PeptiCRAd-1 in Immuno-Oncology
16 Feb 2023 //
GLOBENEWSWIRE
Valo Secures EUR 2.23 million from the European Innovation Council
14 Feb 2023 //
GLOBENEWSWIRE
Valo Therapeutics selects Exothera to develop oncolytic Adenovirus manufacturing
11 Jan 2023 //
GLOBENEWSWIRE
Valo Therapeutics Announces Scientific Advisory Board
02 Aug 2022 //
PRNEWSWIRE
Valo Therapeutics Acquires PeptiCHIP Technology Enabling Rapid Identification
26 Jul 2022 //
PRNEWSWIRE
Valo Tx Appoints Experienced Life Sciences Executive Anthony Giovinazzo to Board
27 Jun 2022 //
PRNEWSWIRE
Valo Therapeutics Appoints Hemanshu Shah as Chief Business Officer
16 Jun 2022 //
PRNEWSWIRE
Valo Tx Acquires University of Helsinki´s technology on pre-existing immunity
06 Jan 2022 //
PRNEWSWIRE
Valo Therapeutics Acquires University of Helsinki´s technology
06 Jan 2022 //
PRNEWSWIRE
Valo Therapeutics Announces €11m Fundraise to Advance PeptiCRAd Immunotherapy
15 Nov 2021 //
PRNEWSWIRE
Valo Submits Clinical Trial Application for PeptiCRAd-1 with Pembrolizumab
13 Jul 2021 //
PRNEWSWIRE
Valo Acquires University of Helsinki`s PeptiBAC Cancer and Infectious
19 Apr 2021 //
PRNEWSWIRE
Valo buys PeptiBAC cancer and infectious disease vaccination technology
19 Apr 2021 //
PHARMABIZ
Valo and ImmunoScape Collaboration Identifies Immunogenic Peptides
09 Mar 2021 //
PRNEWSWIRE
Valo Raises $190 Million in Series B Financing and Unveils Select Programs
11 Jan 2021 //
PRNEWSWIRE
Flagship`s Valo emerges with $100M and plans to transform R&D
25 Sep 2020 //
FIERCE BIOTECH
Valo Therapeutics Announces Board Appointment of Dr Mai-Britt Zocca
07 Jun 2020 //
PRNEWSWIRE
Valo Therapeutics to use PeptiCRAd technology to develop novel Covid vaccine
27 Apr 2020 //
PHARMABIZ
Valo Therapeutics to Support Development of a Pan - Coronavirus Vaccine
27 Apr 2020 //
PR NEWSWIRE
Targovax & Valo Therapeutics Enter Collab to Develop RAS Neoantigen Coating
22 Apr 2020 //
PR NEWSWIRE
Targovax & Valo Therapeutics Enter Collaboration to Develop RAS Neoantigen
21 Apr 2020 //
PR NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.